Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) SHZ
3.25
-0.04(-1.22%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
3.25
-0.04(-1.22%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
5297
First IPO Date
October 30, 2009
| Name | Title | Pay | Year Born |
| Chun Xu Li | Deputy GM & Director | 0 | 1970 |
| Xiao Zhong Lu | Deputy General Manager | 0 | 1980 |
| Wu Jun Lan | GM & Vice Chairman | 0 | 1975 |
| Wu Sun | Executive Vice President, Chief Financial Officer, Chief Accountant & Director | 0 | 1969 |
| Kun Zhang | Deputy General Manager | 0 | 1976 |
| Rui Qiang Chen | Deputy General Manager | 0 | 1977 |
| Yi Yang | Secretary of the Board of Directors | 0 | 1990 |
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet based therapy. It is also involved in the research and development of various drugs in the areas of sepsis, pulmonary hypertension, leukemia, cardiovascular and cerebrovascular diseases, arthritis, ischemic stroke, HCV, vascular disease, psychosis, and chemotherapy, as well as anesthesia drugs and immunomodulators. The company was founded in 1996 and is based in Tianjin, China.